Biochemical Basis of Malignant Hyperpyrexia

Moulds, R. F. W.; Denborough, M. A.
May 1974
British Medical Journal;5/4/1974, Vol. 2 Issue 5913, p241
Academic Journal
No abstract available.


Related Articles

  • Cot death clue.  // New Scientist;7/13/96, Vol. 151 Issue 2038, p11 

    Reports on an Australian study implicating a hereditary muscle disease in cot death. Death of piglets born with malignant hyperpyrexia when the temperature in their incubators was raised; Risk of cot death in infants with malignant hyperpyrexia.

  • CORRESPONDENCE. Lloyd, June K.; Harris, R.I.; Edmonds, C.J.; Woodrow, J.C.; Lack, J.A.; Braveman, A.M.; Lloyd, W.H.; Elder, G.H.; Magnus, I.A.; Canellos, G.P.; Loughnane, T.; McKenzie, Sheila A.; Isaacs, P.E.T.; Warhurst, D.C.; Spalding, J.M.K.; McNulty, J.G.; Lewis, A.A.; Addenbrooke, D.R.H. // British Medical Journal;1/4/1975, Vol. 1 Issue 5948, p35 

    Presents medical correspondence related to medicine. Emphasis on the chronic diuretic therapy and potassium; Cause of malignant hyperpyrexia; Analysis on the geriatric policies.

  • CORRESPONDENCE.  // British Medical Journal;2/22/1975, Vol. 1 Issue 5955, p453 

    Presents several issues related to medicine in Great Britain. Shortage of organs for transplantation; Deaths in dental chair; Effects of the malignant hyperpyrexia.

  • Isoflurane.  // Reactions Weekly;Sep2015, Vol. 1569 Issue 1, p137 

    The article presents a case study of a 13-year-old boy who developed malignant hyperpyrexia after isoflurane treatment.

  • Evaluation of Creatinine Phosphokinase in Screening Patients for Malignant Hyperpyrexia. Ellis, F. Richard; Clarke, I.M.C.; Modgill, Margaret; Currie, S.; Harriman, D.G.F. // British Medical Journal;8/30/1975, Vol. 3 Issue 5982, p511 

    Evaluates the effectiveness of creatinine phosphokinase (CPK) on screening patients with malignant hyperpyrexia in England. Correlation between the disease and myopathy; Symptoms of the disease; Assessment on the different CPK values at different times.

  • Plasma thrombin-antithrombin complex concentrations in dogs with malignant tumours. Maruyama, H.; Watari, T.; Miura, T.; Sakai, M.; Takahashi, T.; Koie, H.; Yamaya, Y.; Asano, K.; Edamura, K.; Sato, T.; Tanaka, S.; Hasegawa, A.; Tokuriki, M. // Veterinary Record: Journal of the British Veterinary Association;6/25/2005, Vol. 156 Issue 26, p839 

    Examines the plasma thrombin-antithrombin complex concentrations in dogs with malignant tumors. Distribution of plasma thrombin-antithrombin complex concentrations in healthy dogs and dogs with malignant tumors; Hemostatic abnormalities in dogs with hemangiosarcoma; Biochemical basis for the...

  • Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis. Osman, Abdelkarim A.; Khurasani, Mohamed H.; Osman, A A; Khurasani, M H // British Journal of Psychiatry;Oct94, Vol. 165, p548 

    Background: Lethal catatonia and neuroleptic malignant syndrome (NMS) have been suggested to have a common neurochemical cause. We hypothesise that both conditions may be due to a sudden and massive blockade of dopamine neurotransmitters.Method: NMS was diagnosed in...

  • Malignant hyperthermia. Neacsu, Ancuta // Nursing Standard;3/22/2006, Vol. 20 Issue 28, p51 

    Malignant hyperthermia, also known as malignant hyperpyrexia, is a pharmacogenetic condition which can develop during general anaesthesia and can be fatal. The author suggests that more awareness of the condition is needed by ward-based nurses who are involved with patients undergoing surgery....

  • Ecstasy toxicity and the cooling factor. Archer, T. // Emergency Medicine Journal;Aug2008, Vol. 25 Issue 8, p534 

    The article describes the case of a young adult who reportedly had taken eight ecstasy tablets and who presented with characteristics that included a body temperature of 40.1° Celsius. He had been given diazepam intravenously to stop his seizures, in addition to naloxone and normal saline...

  • Availability of essential drugs in Pakistan. Khan, Tariq Hayat // Anaesthesia, Pain & Intensive Care;Jun2009, Vol. 13 Issue 1, p1 

    The author reflects on the availability of drugs, which are essential in Pakistan. He mentions that the drug for malignant hyperpyrexia, dantrolene, is not available in healthcare facilities of the country. He states that morphine and pethidine are not marketed in the country for the health...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics